Biogen teaming with CVS and Cigna
CAMBRIDGE, Mass — Today following the FDA’s approval of Aduhelm (aducanumab) for Alzheimer’s disease, Biogen announced it it working with CVS Health and the intention to enter into a value-based contract with Cigna. Starting in September, CVS will make cognitive screenings available through its Project Health program, which aims to narrow care disparities. The program